Clinical Trial Update: Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric Junction [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating total neoadjuvant therapy for lymph node–positive adenocarcinoma of the esophagus and esophagogastric junction is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Esophagus
• Esophageal Cancer

Snippet

Sponsor: Erasmus Medical Center | Conditions: Esophageal Cancer, Adenocarcinoma of the Esophagus | Phase 2 | Status: RECRUITING